
Objection to the Draft Commission Implementing Regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (D067115-02)
Adopted
Reference: B9-0203/2020
Date: 09.07.2020
GUE/NGLThe Left in the European Parliament (GUE/NGL)
13 Members
Group Voting Result
- 12For
- 0Against
- 0Abstention
- 1Did not vote
Majority of the group: For · no deviations
Majority = position with the most votes in the group; "Did not vote" does not count. In case of a tie there is no majority and no deviators.











